(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LEO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LEO

ST13

US500000074228850

Class

5

Filing

74228850

Registration

1782361

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

10/25/2023

Trademark type

Combined

Nice classes

5

Filing date

12/06/1991

Registration date

07/20/1993

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/25/2023

Last transaction

10/25/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Drawing code

3

Owner type

03

Owner location

BALLERUP, DK

Examiner

SMITH,LAURA E

Law office

G30

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

LEO PHARMA A/S
Leo Pharmaceutical Products Ltd. A/S (Lovens kemiske Fabrik Produktionsaktieselskab)

Representatives

SIMOR L MOSKOWITZ Westerman, Hattori, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations;antibioticantibacterialdiureticantihypertensivevitaminmineral supplementhormoneanti-inflammatoryanalgesic* and * anticoagulantanestheticcytostatic agent preparations

Publications

History of USPTO decisions and trademark events.

36 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/25/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/25/2023

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

10/25/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/25/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/24/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

09/13/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/20/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/05/2013

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/01/2013

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

08/01/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/01/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/01/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

07/16/2013

C.7C

NEW CERTIFICATE UNDER SECTION 7 - PROCESSED

09/26/2011

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

09/08/2011

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/06/2011

ES7R

TEAS SECTION 7 REQUEST RECEIVED

03/22/2011

MAIL

PAPER RECEIVED

03/14/2011

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/23/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/23/2010

CFIT

CASE FILE IN TICRS

02/22/2010

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/21/2004

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/21/2004

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/05/2003

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

06/23/2003

MAIL

PAPER RECEIVED

06/23/2003

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

12/16/1999

PRA8

POST REGISTRATION ACTION MAILED - SEC. 8

11/04/1999

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

06/24/1999

R.PR

REGISTERED-PRINCIPAL REGISTER

07/20/1993

PUBO

PUBLISHED FOR OPPOSITION

12/15/1992

NPUB

NOTICE OF PUBLICATION

11/14/1992

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/27/1992

CNEA

EXAMINER'S AMENDMENT MAILED

08/20/1992

CNRT

NON-FINAL ACTION MAILED

03/10/1992

DOCK

ASSIGNED TO EXAMINER

02/18/1992

Continuous trademark protection

Get notified about every new filing that threatens LEO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.